Article
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Feb 2020
Bråten Line S, Haslemo Tore, Jukic Marin M, Ingelman-Sundberg Magnus, Molden Espen, Kringen Marianne K
Abstract excerpt
Sertraline is an (SSRI-)antidepressant metabolized by the polymorphic CYP2C19 enzyme. The aim of this study was to investigate the impact of CYP2C19 genotype on the serum concentrations of sertraline in a large patient population. Second, the proportions of patients in the various CYP2C19 genotype-defined subgroups obtaining serum concentrations outside the therapeutic range of sertraline were assessed. A total...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
